In this review article, we will describe AGC2 or citrin deficiency starting from the recognition of the disease, discovery of the disease gene for CTLN2 and to pathophysiology of the disease based on the function of AGC2, and therapeutic procedures derived from analysis of food preference. This evidence concerns the gene SLC25A13 and hyperinsulinemic hypoglycemia, familial, 4.